Literature DB >> 6378461

Diffusible suppressor factor from splenic macrophages in murine plasmacytoma.

Y H Chen, P Heller.   

Abstract

The immunosuppressive effect of splenic macrophages (M phi) in mice bearing plasmacytoma was previously shown to be mediated by a diffusible factor. This diffusible suppressor factor (DSF) was found to be non-dialysable and sensitive to heating to 56 degrees C and to the proteolytic action of trypsin. The suppressor factor could be removed from culture supernatants by binding to ligands that specifically bind to corresponding myeloma proteins. DSF from splenic suppressor M phi of mice bearing MOPC 315 was capable of binding dinitrophenyl L-lysine, and that from mice bearing MOPC 104E, dextran S. The suppressor factor apparently cross-reacted with anti-idiotypic antibody to the corresponding myeloma protein, but did not interact with anti-isotypic antibody to mouse immunoglobulins (Ig). A higher concentration of mouse Ig than that found in DSF preparations did not have a suppressive effect. Metabolic inhibitors for RNA and protein, but not DNA synthesis effectively blocked the production of DSF. These findings suggest that DSF is a non-Ig protein that may have a structural similarity to myeloma idiotype. Continuous RNA and protein synthesis is required for the elaboration of DSF by splenic suppressor M phi in cultures.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378461      PMCID: PMC1536073     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Plaque formation in agar by single antibody-producing cells.

Authors:  N K JERNE; A A NORDIN
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

2.  Requirement for adherent cells in the primary and secondary immune response in vitro.

Authors:  O Sjöberg; J Andersson; G Möller
Journal:  Eur J Immunol       Date:  1972-04       Impact factor: 5.532

3.  Primary immune response in cultures of spleen cells.

Authors:  J Marbrook
Journal:  Lancet       Date:  1967-12-16       Impact factor: 79.321

4.  Multiple myeloma and benign monoclonal gammopathy: differentiation by immunofluorescence of lymphocytes.

Authors:  F D Lindström; W R Hardy; B J Eberle; R C Williams
Journal:  Ann Intern Med       Date:  1973-06       Impact factor: 25.391

Review 5.  Antigen-binding myeloma proteins of mice.

Authors:  M Potter
Journal:  Adv Immunol       Date:  1977       Impact factor: 3.543

6.  Passive immunity to murine plasmacytoma by rabbit antiidiotypic antibody to myeloma protein.

Authors:  Y Chen; V Yakulis; P Heller
Journal:  Proc Soc Exp Biol Med       Date:  1976-01

7.  Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

Authors:  S Broder; R Humphrey; M Durm; M Blackman; B Meade; C Goldman; W Strober; T Waldmann
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

8.  Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts.

Authors:  I Kamo; C Patel; J Kateley; H Friedman
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

9.  Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) III. Immunochemical properties of the GAT-specific suppressive factor.

Authors:  J Theze; J A Kapp; B Benacerraf
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

10.  Suppression of the humoral immune response by plasmacytomas: mediation by adherent mononuclear cells.

Authors:  J P Kolb; S Arrian; S Zolla-Pazner
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

View more
  1 in total

1.  Suppression of polyclonal B cell proliferation mediated by supernatants from human myeloma bone marrow cell cultures.

Authors:  D Peest; R Hölscher; R Weber; R Leo; H Deicher
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.